Evidence map›Paper›PMID 32554861›Full record

ArticleAging2020

Treatment strategies of hospitalized patients with coronavirus disease-19.

Yaxiong Huang, Chunlin Cai, Jinglei Zang, Jun Xie, Dan Xu, Fang Zheng, Tao Zhan, Kang Huang, Yikai Wang, Xiao Wang and 3 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.2field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Yaxiong HuangThe First Hospital of Changsha City, Changsha 410005, Hunan, China.
Chunlin CaiThe First Hospital of Changsha City, Changsha 410005, Hunan, China.
Jinglei ZangChangsha Health Vocational College, Changsha 410100, Hunan, China.
Jun XieThe First Hospital of Changsha City, Changsha 410005, Hunan, China.
Dan XuThe First Hospital of Changsha City, Changsha 410005, Hunan, China.
Fang ZhengThe First Hospital of Changsha City, Changsha 410005, Hunan, China.
Tao ZhanThe First Hospital of Changsha City, Changsha 410005, Hunan, China.
Kang HuangThe First Hospital of Changsha City, Changsha 410005, Hunan, China.
Yikai WangEmory University Rollins School of Public Heath, Atlanta, GA 30322, USA.
Xiao WangICF, 3 Corporate Square NE., Atlanta, GA 30329, USA.
Zhe-Yu HuHunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China.
Yapeng DengHunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China.
Yuanlin XieThe First Hospital of Changsha City, Changsha 410005, Hunan, China.
The First Hospital of Changsha · CNCentral South University · CNChangsha Hospital for Maternal and Child Health Care · CNEmory University · USHunan Cancer Hospital · CNICF International (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the outbreak of coronavirus disease-19 (COVID-19), Changsha faced an increasing burden of treating the Wuhan migrants and their infected patients. This study is a retrospective, single-center case series of the 238 consecutive hospitalized patients with confirmed COVID-19 at the First Hospital of Changsha city, China, from 01/21 to 02/14, 2020; the final date of follow-up was 02/27, 2020. Of 238 patients 43.7% visited Wuhan, 58.4% got in touch with Wuhan people, and 47.5% had contacted with diagnosed patients. 37.8% patients had family members infected. 190 cases had mild / general disease, and 48 cases had severe / critical disease. Compared to mild or general patients, more severe or critical patients visited Wuhan (59.6% vs 40.2%;

Indexed as

BetacoronavirusRespiration, ArtificialAdultAnti-Inflammatory Agents, Non-SteroidalAntiviral AgentsChinaChloroquineCoronavirus InfectionsCOVID-19Drug CombinationsDrugs, Chinese HerbalFemalegamma-GlobulinsGlucocorticoidsHospitalizationHumansAnti-Inflammatory Agents, Non-SteroidalAntiviral AgentsChloroquinechloroquine diphosphateDrug CombinationsDrugs, Chinese Herbalgamma-GlobulinsGlucocorticoidsImmunologic FactorsIndolesInterferonsLopinavirlopinavir-ritonavir drug combinationOxygenRitonavirSulfidesumifenovirXuebijingcoronasvirus disease-19COVID-19epidemiological and clinical characteristicsoutside Wuhanprognosistreatment strategies

Identifiers

PMID32554861
PMCPMC7343487
OpenAlexW3036097891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.